2023
Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration
Villamagna A, Beste L, Borgerding J, Lowy E, Hauser R, Ross D, Maier M. Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration. Journal Of Addiction Medicine 2023, 17: 387-393. PMID: 37579093, DOI: 10.1097/adm.0000000000001134.Peer-Reviewed Original ResearchConceptsSubstance use disordersVeterans Health AdministrationMental health diagnosesUse disordersTesting ratesCase ratesTest positivityHealth AdministrationSUD groupSingle substance use disorderVeterans Health Administration patientsMultiple substance use disordersStimulant useHealth diagnosisHIV test positivityInfections (STI) testing ratesNational retrospective analysisHigh STI ratesLow testing ratesStimulant use disorderAlcohol use disorderInfection testingNational cohortSTI ratesRetrospective analysis
2020
Paget disease of the breast: A national retrospective analysis of the US population
Sisti A, Huayllani MT, Restrepo DJ, Boczar D, Advani P, Lu X, Spaulding AC, Ball CT, McLaughlin SA, Forte AJ. Paget disease of the breast: A national retrospective analysis of the US population. Breast Disease 2020, 39: 119-126. PMID: 32390594, DOI: 10.3233/bd-200439.Peer-Reviewed Original ResearchConceptsNational Cancer DatabasePaget's diseaseComplete mastectomyPartial mastectomyCommon treatmentSurvival rateRegional lymph node metastasisBlack race/ethnicityHigher cancer stageNational retrospective analysisOverall survival rateLymph node metastasisLarger tumor sizeHigh tumor gradeRace/ethnicityMedian ageNode metastasisFemale patientsShorter survivalTumor sizeCancer DatabaseCancer stageTumor gradeTreatment characteristicsMetastatic cancer
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply